APA

Hosoi H., Imadome K., Tamura S., Kuriyama K., Murata S., Yamashita Y., Mushino T., Oiwa T., Kobata H., Nishikawa A., Nakakuma H., Hanaoka N., Isobe Y., Ohshima K. & Sonoki T. (20170807). An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. : Leukemia research.

Chicago

Hosoi Hiroki, Imadome Ken-Ichi, Tamura Shinobu, Kuriyama Kodai, Murata Shogo, Yamashita Yusuke, Mushino Toshiki, Oiwa Takehiro, Kobata Hiroshi, Nishikawa Akinori, Nakakuma Hideki, Hanaoka Nobuyoshi, Isobe Yasushi, Ohshima Kouichi and Sonoki Takashi. 20170807. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. : Leukemia research.

Harvard

Hosoi H., Imadome K., Tamura S., Kuriyama K., Murata S., Yamashita Y., Mushino T., Oiwa T., Kobata H., Nishikawa A., Nakakuma H., Hanaoka N., Isobe Y., Ohshima K. and Sonoki T. (20170807). An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. : Leukemia research.

MLA

Hosoi Hiroki, Imadome Ken-Ichi, Tamura Shinobu, Kuriyama Kodai, Murata Shogo, Yamashita Yusuke, Mushino Toshiki, Oiwa Takehiro, Kobata Hiroshi, Nishikawa Akinori, Nakakuma Hideki, Hanaoka Nobuyoshi, Isobe Yasushi, Ohshima Kouichi and Sonoki Takashi. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. : Leukemia research. 20170807.